Nip7 Antibody

What is NIP7 and what cellular functions does it serve?

NIP7 is a nucleolar protein required for proper 34S pre-rRNA processing and 60S ribosome subunit assembly. It plays a critical role in pre-rRNA maturation, particularly in the processing of internal transcribed spacer 1 (ITS1). The protein is restricted to the nuclear compartment and co-sediments with complexes having molecular masses in the 40S-80S range, suggesting association with nucleolar pre-ribosomal particles. Downregulation of NIP7 affects cell proliferation and causes an imbalance in the 40S/60S ribosomal subunit ratio, indicating its importance in ribosome biogenesis pathways . The protein is also known by several alternative names including CGI-37, HSPC031, HSPC180, KD93, and 60S ribosome subunit biogenesis protein NIP7 homolog .

What types of NIP7 antibodies are commercially available?

Several types of NIP7 antibodies are available for research purposes. These include rabbit polyclonal antibodies that recognize specific regions of the NIP7 protein, particularly the C-terminal domain. For example, antibody ABIN202042 is a rabbit polyclonal antibody that targets the C-terminus of human NIP7 . Additionally, there are antibodies that recognize full-length NIP7 or specific amino acid sequences within the protein. The antibodies are available in unconjugated forms for various applications including Western blotting, immunohistochemistry, and immunofluorescence .

Which species show reactivity with available NIP7 antibodies?

NIP7 antibodies show cross-reactivity with multiple species due to the high conservation of the NIP7 protein sequence across species. Commercially available antibodies show reactivity with human, mouse, rat, cow, pig, horse, zebrafish, and monkey samples . BLAST analysis indicates that some NIP7 antibodies have 100% sequence identity with NIP7 from humans, chimpanzees, gorillas, orangutans, gibbons, marmosets, mice, pandas, bovines, bats, horses, and pigs. There is also high sequence conservation (92%) with NIP7 from rats, elephants, rabbits, opossums, and guinea pigs . This wide range of reactivity makes these antibodies versatile tools for comparative studies across species.

What are the validated applications for NIP7 antibodies?

NIP7 antibodies have been validated for several experimental applications. Western blotting (WB) is the most common application, with antibodies successfully detecting the predicted 20 kDa NIP7 protein band in various cell lysates including HEK293T, mouse kidney tissue, and H9C2 whole cell lysates . Immunohistochemistry (IHC), including paraffin-embedded sections (IHC-P), is another validated application . Some NIP7 antibodies have also been validated for immunofluorescence (IF) and fluorescence-activated cell sorting (FACS) applications. These diverse applications make NIP7 antibodies valuable tools for studying protein expression, localization, and function in various experimental contexts.

How should researchers validate NIP7 antibody specificity?

For validating NIP7 antibody specificity, researchers should employ a multi-method approach:

• Positive controls: Use cell lines or tissues known to express NIP7, such as HEK293T cells, which show clear bands in Western blot analysis .

• Knockdown validation: Compare antibody signals between control cells and cells where NIP7 has been downregulated using RNAi techniques. Studies have shown that NIP7 downregulation can be confirmed by both RT-qPCR and Western blot, with protein levels significantly reduced in knockdown cells .

• Predicted band size verification: Check that the observed band corresponds to the predicted molecular weight of NIP7 (approximately 20 kDa) .

• Cross-reactivity testing: Test the antibody against samples from multiple species if cross-species research is planned, confirming reactivity matches the predicted pattern based on sequence homology.

What are the optimal conditions for Western blotting with NIP7 antibodies?

For optimal Western blotting results with NIP7 antibodies, consider the following methodological recommendations:

• Sample preparation: Cell lysates from HEK293T, mouse kidney tissue, or H9C2 cells have been successfully used to detect NIP7 . For RNA interference studies, total protein extracts can be prepared from cell pellets by sonication in extraction buffer.

• Protein loading: Since NIP7 is a relatively low abundance protein involved in ribosome biogenesis, ensure adequate protein loading (typically 20-50 μg of total protein extract per lane).

• Primary antibody concentration: Optimal dilutions should be determined empirically, but typical working dilutions for polyclonal NIP7 antibodies range from 1:1000 to 1:5000.

• Detection systems: Both colorimetric and chemiluminescent detection systems are suitable, with enhanced chemiluminescence (ECL) providing better sensitivity for detecting low abundance NIP7.

• Controls: Include both positive controls (known NIP7-expressing samples) and loading controls (such as actin) to normalize protein levels .

How can NIP7 antibodies be used to study ribosome biogenesis defects?

NIP7 antibodies serve as valuable tools for investigating ribosome biogenesis defects through multiple approaches:

• Subcellular localization studies: Immunofluorescence with NIP7 antibodies can reveal the protein's nucleolar localization and potential redistribution under stress conditions or in disease states affecting ribosome biogenesis.

• Protein complex analysis: Co-immunoprecipitation using NIP7 antibodies followed by mass spectrometry can identify NIP7 protein interaction partners in pre-ribosomal complexes. Studies have shown that NIP7 co-sediments with complexes in the 40S-80S range .

• Ribosomal subunit imbalance detection: Western blotting with NIP7 antibodies, combined with polysome profiling, can help assess the impact of treatments or mutations on the 40S/60S subunit ratio. NIP7 downregulation has been shown to cause an imbalance in this ratio .

• Cell cycle analysis: FACS combined with NIP7 immunostaining can reveal correlations between NIP7 expression levels and cell cycle progression, as NIP7 depletion leads to accumulation of cells in G0-G1 phases .

What insights can NIP7 antibody-based studies provide into pre-rRNA processing?

Research using NIP7 antibodies has revealed crucial insights into pre-rRNA processing pathways:

• Processing defect identification: NIP7 downregulation affects pre-rRNA processing, causing decreased 34S pre-rRNA levels and increased 26S and 21S pre-rRNA concentrations. This suggests that processing at site 2 is particularly affected in NIP7-depleted cells .

• Relationship with nuclear export: Combined treatment with leptomycin B (which inhibits exportin Crm1/Xpo1 and blocks ribosome subunit export) and NIP7 downregulation showed that NIP7 is particularly required for processing of the ITS1 sites .

• RNA-protein interaction analysis: Studies combining NIP7 antibodies with RNA immunoprecipitation have shown that human NIP7 interacts with poly-U and poly-AU RNAs in vitro, with higher affinity for poly-AU sequences, suggesting a role in binding structured RNAs during ribosome biogenesis .

How can researchers use NIP7 antibodies to investigate cell proliferation defects?

NIP7 antibodies can be employed to investigate cell proliferation defects through several experimental approaches:

• Cell cycle analysis: Studies have shown that NIP7 downregulation leads to accumulation of cells in the G0-G1 phases and reduction in S phase, indicating a role in cell cycle progression . Researchers can combine NIP7 immunostaining with FACS analysis to correlate NIP7 expression levels with cell cycle distribution.

• Proliferation marker correlation: Dual immunostaining with NIP7 antibodies and proliferation markers (Ki-67, PCNA) can reveal relationships between NIP7 expression and cell proliferation status.

• Rescue experiments: Researchers can perform knockdown-rescue experiments where endogenous NIP7 is depleted followed by expression of exogenous wild-type or mutant NIP7. Subsequent immunoblotting with NIP7 antibodies can confirm expression levels while proliferation assays assess functional rescue.

• Stress response studies: NIP7 antibodies can track protein expression and localization changes during cellular stress responses that affect ribosome biogenesis and cell proliferation.

What are common issues when using NIP7 antibodies and how can they be resolved?

Researchers may encounter several challenges when working with NIP7 antibodies:

• Low signal intensity: NIP7 is a relatively low abundance protein. To enhance detection:

  • Increase protein loading (40-60 μg per lane)

  • Optimize antibody concentration

  • Use enhanced chemiluminescence detection systems

  • Consider signal amplification methods such as tyramide signal amplification for IHC

• Multiple bands in Western blot: This could indicate degradation products or cross-reactivity. To address:

  • Use freshly prepared samples with protease inhibitors

  • Optimize blocking conditions (5% BSA may reduce background compared to milk)

  • Perform additional specificity controls such as peptide competition assays

  • Compare results with alternative NIP7 antibodies targeting different epitopes

• Variable immunostaining patterns: For consistent results:

  • Standardize fixation protocols (paraformaldehyde fixation may better preserve nuclear antigens)

  • Optimize antigen retrieval methods for IHC

  • Include positive control samples with known NIP7 expression

What controls should be included in experiments using NIP7 antibodies?

Proper experimental controls are essential for reliable NIP7 antibody-based research:

• Positive controls:

  • Cell lines with confirmed NIP7 expression (HEK293T, H9C2)

  • Tissues known to express NIP7 (kidney tissue has been validated)

• Negative controls:

  • Primary antibody omission controls

  • Isotype controls (rabbit IgG for rabbit polyclonal NIP7 antibodies)

  • NIP7-depleted cells (siRNA or shRNA knockdown)

• Loading and normalization controls:

  • For Western blotting, include housekeeping proteins (actin, GAPDH)

  • For RT-qPCR validation of knockdown efficiency, appropriate reference genes should be used (actin for HEK293 cells, HPRT for HeLa cells, and 36B4 for MCF10A cells have been validated)

• Specificity controls:

  • Peptide competition assays with the immunizing peptide

  • Comparison of results with alternative NIP7 antibodies

  • Correlation of protein detection with mRNA levels

How should researchers interpret conflicting results from NIP7 antibody experiments?

When faced with conflicting results from NIP7 antibody experiments, researchers should:

• Compare antibody characteristics:

  • Different antibodies may target different epitopes of NIP7

  • Check if antibodies recognize different isoforms or post-translationally modified versions

  • Verify the species reactivity profiles match your experimental system

• Evaluate experimental conditions:

  • Different fixation methods can affect epitope accessibility

  • Buffer conditions and blocking agents can influence antibody binding

  • Sample preparation methods may impact protein detection

• Consider biological variables:

  • NIP7 expression and localization may vary with cell cycle phase

  • Cell type-specific differences in NIP7 function may exist

  • Stress conditions can alter NIP7 expression or localization

• Employ orthogonal techniques:

  • Validate antibody results with RNA interference (siRNA or shRNA)

  • Confirm protein expression with mass spectrometry

  • Use tagged expression constructs as alternative detection methods

What are emerging applications for NIP7 antibodies in research?

NIP7 antibodies continue to evolve as essential tools for understanding fundamental cellular processes:

• Ribosome biogenesis disorders: NIP7 antibodies may help characterize ribosomopathies, a group of diseases caused by defects in ribosome production or function.

• Cancer research: Given the link between ribosome biogenesis and cancer progression, NIP7 antibodies could serve as tools for investigating dysregulated ribosome production in cancer cells.

• Stress response studies: NIP7 antibodies can help examine how cellular stress impacts ribosome biogenesis pathways.

• Developmental biology: These antibodies may help elucidate the role of NIP7 in organism development, where precise control of ribosome biogenesis is critical.

• Evolutionary studies: The high conservation of NIP7 across species makes these antibodies valuable for comparative studies of ribosome biogenesis across evolutionary lineages.